Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Management Appointments

17 Dec 2008 17:52

RNS Number : 3515K
Phorm Inc
17 December 2008
 



Phorm, Inc. ("Phorm" or the "Company")

Management Appointments

Phorm (AIM: PHRM and PHRX), the innovative digital advertising business, today announces three key executive appointments. These changes will strengthen the Company's leadership team through the next important phase of its development. The UK based executive management will ensure the deliverability of the Group's core strategic objective of deploying Phorm's technology both in the UK and internationally whilst managing cash resources in a prudent fashion.

Nan Richards is appointed Deputy Chief Executive Officer based in London. Nan's primary responsibility will be to work with Chief Executive, Kent Ertugrul, to deliver Phorm's operational goals. Nan Richards was previously President of Turner Broadcasting System Europe, a division of Time Warner. She brings with her a wealth of operational and strategic experience having spent 20 years working on Turner's leading broadcast brands including CNN, Cartoon Network and TCM. 

Hugo Drayton, UK Chief Executive, will leave the Company by mutual agreement at the end of 2008, though he will remain an advisor to the Company. Hugo Drayton commented: "My time with Phorm has been exciting and rewarding. Whilst I am looking forward to exploring new challenges in the fast-evolving media world, I am delighted that I will continue to contribute to the dynamic, industry-changing future of Phorm. I am very happy with the progress we've made in recent months with our ISP partners and our advertising and publishing clients. In 2009 we expect that Phorm's Open Internet Exchange (OIX) will be commercially deployed and I am very proud that the team we have established is now fully prepared to deliver on the Company's enormous potential."

Andrew Croxson is appointed Global CFO on an interim basis. Andrew joins from the Technology, Media and Telecommunications (TMT) specialists Ingenious Consulting. Prior to that, Andrew was a partner at Spectrum Strategy Consultants. He is an ACA qualified chartered accountant and has a Masters Degree from both Oxford and Cambridge Universities. As well as Andrew's significant financial knowledge, he also brings deep experience of advising brand leading media and technology companies and strategic insights into building and scaling global operations. He will replace Lynne Millar who has resigned as UK CFO.

Nick Barnett, currently Phorm's UK Commercial Director, is promoted to the newly created role of UK Managing Director based in London. Nick will be responsible for the UK business working with ISPs on the trial and deployment of Phorm's technology as well as overseeing our commercial relationships with advertisers, publishers and ad networks. Before joining Phorm, Nick was VP of Corporate Strategy and Development at Telefonica O2 Europe and prior to that he was a senior manager with McKinsey & Company specialising in the TMT sector.

Kent Ertugrul, Chief Executive of Phorm, commented: "I'd like to welcome Nan, Andrew, and Nick to their new roles. Their appointments are central to the delivery of our strategic objectives through the next important phase of our development.

 

"I thank both Hugo and Lynne for their significant contributions and wish them well in their future endeavours. They have helped lay the foundations for a successful commercial launch in the UK and beyond. I am delighted that Hugo will build on his previous achievements with Phorm as an advisor.

"We have made significant progress in the development of partnerships and the testing of our technology. I am also pleased that we have completed the trial with BT and look forward to moving to the next stage of development.

"I am confident that we have the right talent at both the Board and executive level to deliver on the huge potential of our technology and the business opportunity that lies ahead. I believe that we are now uniquely placed to lead the introduction of privacy-assured behavioural advertising across the whole of the Internet."

For Phorm Enquiries:

Kent Ertugrul (Chief Executive)

+44 20 7638 9571

Citigate Dewe Rogerson

+44 20 7638 9571

Simon Rigby

Justin Griffiths

Canaccord Adams Limited

+44 20 7050 6500

(Nominated Adviser)

Mark Williams

Andrew Chubb

About Phorm:

Phorm is an innovative technology company specialising in delivering behaviourally and contextually targeted advertising while preserving users' personal privacy and security. Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Ad Networks and Advertisers.

Phorm is a Delaware, US incorporated company, with offices in New York and London. The Company was admitted to the AIM market of the London Stock Exchange in 2004 and has over 100 employees.

For more information, please visit: www.phorm.com http://www.phorm.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAFKOKQOBDDOBD
Date   Source Headline
22nd Feb 20088:25 amRNSStockholder Meeting
14th Feb 20087:01 amRNSISP agreements
1st Feb 20088:55 amRNSExercise of Options
28th Jan 20087:01 amRNSTransfer of Shares
15th Jan 20087:00 amRNSManagement Appointment
11th Jan 20085:01 pmRNSExercise of Options
20th Dec 20075:47 pmRNSDirector/PDMR Shareholding
17th Dec 20071:56 pmRNSExercise of Options
30th Nov 20075:32 pmRNSHolding(s) in Company
7th Nov 20072:06 pmRNSExercise of Options
1st Oct 20077:02 amRNSDirectorate Change
28th Sep 20078:02 amRNSInterim Results
12th Sep 20079:33 amRNSHolding(s) in Company
20th Aug 20077:00 amRNSAIM Rule 26
27th Jul 20073:27 pmRNSDirector/PDMR Shareholding
17th Jul 200710:03 amRNSDirector Change - Replacement
17th Jul 20079:12 amRNSDirectorate Change
13th Jul 20071:26 pmRNSExercise of options
18th Jun 20074:50 pmRNSNotification of Interest
18th Jun 20077:01 amRNSAdditional Listing
15th Jun 20077:58 amRNSStmnt re Share Price Movement
6th Jun 20074:11 pmRNSHolding(s) in Company
21st May 20077:02 amRNSDirectorate Change
16th May 20074:17 pmRNSIssue of Equity
4th May 20077:00 amRNSRe-Organisation
3rd May 20077:01 amRNSRe-Organisation
2nd May 20072:01 pmRNSPress speculation
1st May 20078:20 amRNSSch 1 Update - Phorm, Inc.
27th Apr 20074:27 pmRNSSch 1 Update - Phorm, Inc.
26th Apr 200711:52 amRNSNotification of Holding
26th Apr 200711:24 amRNSResult of AGM
24th Apr 20077:02 amRNSAnnual Results
12th Apr 20073:45 pmRNSExercise of Options
2nd Apr 200711:02 amRNSSchedule 1 - Phorm, Inc
2nd Apr 20077:02 amRNSNotice of AGM
8th Mar 20077:04 amRNSDirectorate Change
27th Feb 20077:04 amRNSIssue of Equity
1st Feb 200712:40 pmRNSHolding(s) in Company
21st Dec 20063:33 pmPRNTotal Voting Rights
6th Dec 200612:21 pmPRNAdditional Listing
3rd Nov 20063:05 pmPRNStatement re Share Price Movement
18th Aug 200610:45 amPRNAdditional Listing
28th Jul 20067:00 amPRNAdditional Listing
25th Jul 200612:00 pmPRN121Media appoints David Dorman as Adviser
25th Jul 200610:45 amPRNShare Incentive Plan
21st Jul 20067:00 amPRNUpdate on Trading in and settlement of common shares
20th Jul 20067:00 amPRNDirector/PDMR Shareholding
19th Jul 20067:00 amPRNUpdate re: ISP Partnership Strategy
23rd Jun 20064:12 pmPRNFormal Notice
16th Jun 20067:00 amPRNAppointment of EVP Operations

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.